NexgenRx Inc. (TSXV:NXG)

NexgenRx Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	16.66	15.9	13.29	12.57	11.79	10.39
Other Revenue	1.06	0.58	0.56	0.21	0.05	0.18
Revenue	17.71	16.48	13.85	12.78	11.84	10.57
Revenue Growth (YoY)	11.77%	18.99%	8.33%	7.94%	12.01%	10.82%
Cost of Revenue	3.31	3.35	3.03	2.6	2.03	1.38
Gross Profit	14.41	13.12	10.82	10.18	9.81	9.2
Selling, General & Admin	11.17	10.64	9.62	8.43	6.18	6.49
Amortization of Goodwill & Intangibles	1.01	1.05	1.12	1.14	1.02	0.65
Operating Expenses	12.44	11.92	10.96	9.9	7.61	7.51
Operating Income	1.96	1.2	-0.14	0.29	2.2	1.69
Interest Expense	-	-0.03	-0.03	-0.02	-0.06	-0.21
Interest & Investment Income	0	-	-	-	-	-
Other Non Operating Income (Expenses)	-0.15	-0.14	-0.13	-0.13	-0.13	-0.14
EBT Excluding Unusual Items	1.82	1.03	-0.31	0.13	2.01	1.34
Other Unusual Items	-	-	-	-	-	0.47
Pretax Income	1.86	1.03	-0.31	0.13	2.01	1.81
Income Tax Expense	0.41	0.41	0.03	0.16	-2.01	-0.31
Net Income	1.44	0.61	-0.33	-0.02	4.02	2.12
Preferred Dividends & Other Adjustments	0.2	0.2	0.2	-	-	-
Net Income to Common	1.24	0.42	-0.53	-0.02	4.02	2.12
Net Income Growth	466.93%	-	-	-	89.91%	-
Shares Outstanding (Basic)	71	71	71	70	70	70
Shares Outstanding (Diluted)	77	77	71	70	75	74
Shares Change (YoY)	8.26%	8.51%	0.28%	-6.01%	0.88%	6.10%
EPS (Basic)	0.02	0.01	-0.01	-0.00	0.06	0.03
EPS (Diluted)	0.02	0.01	-0.01	-0.00	0.05	0.03
EPS Growth	-	-	-	-	86.21%	-
Free Cash Flow	2.48	1.06	1.2	0.68	3.7	2.53
Free Cash Flow Per Share	0.03	0.01	0.02	0.01	0.05	0.03
Dividend Per Share	0.010	0.010	0.010	0.010	-	-
Gross Margin	81.33%	79.65%	78.14%	79.67%	82.88%	86.99%
Operating Margin	11.08%	7.27%	-1.04%	2.25%	18.57%	15.97%
Profit Margin	7.03%	2.53%	-3.83%	-0.18%	33.93%	20.01%
Free Cash Flow Margin	14.00%	6.46%	8.67%	5.30%	31.23%	23.95%
EBITDA	1.39	1.41	0.07	1.53	3.31	2.41
EBITDA Margin	7.87%	8.53%	0.49%	11.98%	27.98%	22.82%
D&A For EBITDA	-0.57	0.21	0.21	1.24	1.11	0.72
EBIT	1.96	1.2	-0.14	0.29	2.2	1.69
EBIT Margin	11.08%	7.27%	-1.04%	2.25%	18.57%	15.97%
Effective Tax Rate	22.22%	40.14%	-	116.66%	-	-
Revenue as Reported	17.71	16.48	13.85	12.78	11.84	11.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.